Organ support & nutrition

Impact of post-decannulation high fever on mortality in patients with severe acute respiratory distress syndrome (ARDS) treated with veno-venous extracorporeal membrane oxygenation (ECMO): a multicenter retrospective study

J Intensive CarePublished Post hoc analysis of a multicenter retrospective registry

Authors' conclusion

Post-decannulation high fever occurs in nearly one-fourth of patients with severe ARDS treated with V-V ECMO. Its association with mortality appears to differ depending on the infection status at decannulation

Study context

Population
Adults with severe ARDS successfully weaned off V–V ECMO, 24 institutions in Japan, 2012–2022
Participants
522 adults · 24 institutions
Comparison
Post-decannulation high fever vs no fever
  • High-fevern = 121
Primary endpoint
In-hospital mortality
Follow-up
90 days
Methodological detailsmulticentre, Cox proportional hazards models
  • Multicentre
  • Cox proportional hazards models

Primary result

As reported in the abstract

Hazard ratio

0.92

95% CI 0.55–1.56

P = 0.770

By group

High-fever vs No-fever
HR 0.92 (95% CI 0.55–1.56); P = 0.770

Further findings

OutcomeHR (95% CI)P value
90-day in-hospital mortality, patients with infection (subgroup)0.33 (0.12–0.89)P = 0.045
90-day in-hospital mortality, patients without infection (subgroup)2.25 (1.23–4.11)P = 0.011

Incidence of post-decannulation high fever · within 3 days after decannulation

Developed high fever
121 (23.2%)

Original publication

Impact of post-decannulation high fever on mortality in patients with severe ARDS treated with veno-venous ECMO: a multicenter retrospective study. J Intensive Care. Published 11 February 2026. doi:10.1186/s40560-026-00865-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.